These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
9. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model. Liarakos VS; Papaconstantinou D; Vergados I; Douvali M; Theodossiadis PG Eur J Ophthalmol; 2014; 24(3):299-308. PubMed ID: 24242219 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control]. Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009 [TBL] [Abstract][Full Text] [Related]
11. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836 [TBL] [Abstract][Full Text] [Related]
12. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD. Lim JI; Niec M; Wong V Br J Ophthalmol; 2015 May; 99(5):618-23. PubMed ID: 25376617 [TBL] [Abstract][Full Text] [Related]